Market leading late phase and real world clinical trial technology, tailored to suit the needs of any post approval study
Book a DemoTailored and flexible solutions that support the complex nature of post approval research
Our cutting edge technology, Baseline Plus, is the only single end to end clinical trial platform, specifically designed to meet the unique needs of late phase, real world and post approval research studies. We collaborate directly with each of our clients to deliver innovative solutions which are tailored to meet your unique post approval study requirements. Trusted by pharmaceutical and biotech organisations across the globe, we can deliver rapid study builds, suitable to any regulatory setting, which improve operational efficiencies, enabling you to deliver better data, faster.
One single clinical trial platform, designed to meet the needs of any post approval study requirements
Our flexible technology can support any post approval study design. Baseline Plus provides an end to end set of modules that plug into the varied designs found in post approval studies, without the need for multiple systems.
Baseline Plus contains eCOA, ePRO, eConsent and eDiary modules enabling data from patients and physicians to be captured in one place.
Collaborating with 90% of the top global pharmaceutical companies
Over 200 studies delivered in the last 4 years
Proven to reduce data management costs by over 60%